SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Demant A/S WILYY OTC

Other OTC • Healthcare • Medical - Devices • DK • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Demant A/S (WILYY) is a Medical - Devices company in the Healthcare sector, currently trading at $16.30. It has a SharesGrow Score of 59/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Financials: revenue is $23.0B, +5.4%/yr average growth. Net income is $1.5B, growing at -5.4%/yr. Net profit margin is 6.7% (thin). Gross margin is 75.6% (+1.2 pp trend).

Balance sheet: total debt is $21.0B against $9.8B equity (Debt-to-Equity (D/E) ratio 2.13, leveraged). Current ratio is 1.36 (adequate). Debt-to-assets is 53.7%. Total assets: $39.1B.

Analyst outlook: 3 / 9 analysts rate WILYY as buy (33%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 40/100 (Partial), Past 100/100 (Pass), Health 33/100 (Fail), Moat 74/100 (Pass), Future 20/100 (Fail), Income 45/100 (Partial).

WILYY SharesGrow Score Overview

59/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 40/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 33/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 74/100

Gross margin is + market cap

FUTURE 20/100

Analyst outlook — as buy

INCOME 45/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — WILYY

WILYY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

WILYY: +5.4%/yr revenue is, -5.4%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

WILYY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet WILYY: Debt-to-Equity (D/E) ratio 2.13 (leveraged), Current ratio is 1.36 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

WILYY: Gross margin is 75.6% (+1.2 pp trend), $7B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 74/100. ≥ 70 = Pass.

View details →

Analyst outlook: 3 / 9 analysts rate WILYY as buy (33%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

WILYY: Net profit margin is 6.7%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range13.45-21.93

Volume1

Avg Volume (30D)60

Market Cap$6.89B

Beta (1Y)0.74

Share Statistics

EPS (TTM)3.52

Shares Outstanding$422.62M

IPO Date2011-06-24

Employees19,917

CEOSøren Nielsen

Financial Highlights & Ratios

Revenue (TTM)$22.97B

Gross Profit$17.37B

EBITDA$5.37B

Net Income$1.55B

Operating Income$3.91B

Total Cash$1.33B

Total Debt$20.99B

Net Debt$19.66B

Total Assets$39.07B

Price / Earnings (P/E)4.6

Price / Sales (P/S)0.3

Analyst Forecast

Rating ConsensusHold

Analysts Covering9

Buy 33% Hold 56% Sell 11%

Company Info

CountryDK

ExchangeOther OTC

CurrencyUSD

ISINUS24803R1095

Price Chart

WILYY

Demant A/S ↗ · Other OTC

Healthcare • Medical - Devices

13.45 52WK RANGE 21.93

People Also View

Siemens Healthineers AG

Sonova Holding AG

Cochlear Limited

GN Store Nord A/S

GN Store Nord A/S

CONMED Corporation

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message